ArticleProceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data2025
IRIS: Interpretable Risk Clustering Intelligence for Survival Analysis.
Article in Proceedings : ... IEEE International Conference on Big Data. IEEE International Conference on Big Data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Survival analysis models have evolved significantly with deep learning approaches, yet often lack interpretability and meaningful risk stratification capabilities. We present Interpretable Risk Clustering Intelligence for Survival Analysis (IRIS), a novel framework that addresses the critical task of risk clustering while enhancing both input-level and model-body interpretability. Unlike traditional survival models that perform post-hoc risk clustering, IRIS learns to cluster patients into meaningful risk groups directly from data while providing transparent feature importance estimation through feature contribution functions. We validate IRIS on several benchmark datasets, a real-world Alzheimer's disease dataset, and an electronic health record dataset, showing superior performance in risk clustering and predictive reliability with only a modest decrease in time-to-event prediction accuracy compared to state-of-the-art methods. Our results show that IRIS successfully balances the trade-off between interpretability and prediction performance in risk-based survival analysis, offering clinicians actionable insights for treatment planning and resource allocation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.